Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

A longevity-linked metabolite restored key memory processes in Alzheimer’s models, highlighting aging biology as a promising therapeutic target. Singapore ranks among the countries with the longest ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

In the heavy-duty truck segment, Fan said methanol-hydrogen trucks show several advantages over battery electric models: ...

Transverse colon samples from confirmed Alzheimer’s disease cases showed distinct gut microbiome and proteomic shifts, ...

Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...

A new Bill formally recognizes e-sports and mind sports like chess as official sports in Singapore, expanding SportSG's role ...